Skip to main content
. 2016 Sep 6;113(38):10649–10654. doi: 10.1073/pnas.1605885113

Fig. S4.

Fig. S4.

Up-regulation of CTLA-4 after addition of a CD45 inhibitor. CTLA-4 expression on DesTCR T cells activated by MR−/− BM-DCs in the presence or absence of 1 μM CD45 inhibitor N-(9,10-dioxo-9,10-dihydro-phenanthren-2-yl)-2,2-dimethyl-propionamide (SF1670).